News

Pieris Pharmaceuticals establishes US headquarters in Boston, Massachusetts

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, announced today a key addition to its senior leadership team with the appointment of Darlene Deptula-Hicks as Senior Vice President and Chief Financial Officer. The Company also announced the transition of its corporate headquarters from Freising, Germany to Boston, Massachusetts.

 

Further readings:

http://www.bio-m.org/en/press-releases/details/3932.html


Newsletter

Subscribe

Archive